MDMA Addiction Treatment in Iowa

MDMA, ecstasy, and molly are the same drug. Our care is therapy-led, with integrated dual diagnosis for the depression and anxiety underneath it.

Radix Recovery provides MDMA addiction treatment in Cedar Rapids, Iowa, combining behavioral therapies like cognitive behavioral therapy and an integrated dual-diagnosis assessment for the depression and anxiety that so often sit underneath MDMA, ecstasy, and molly use. There is no FDA-approved medication for MDMA use disorder, so our treatment is therapy-led, not pill-based. Because pills and powder are so often adulterated, we assess what you have actually been taking.

The reality, in brief

Days 2-4

When the crash peaks

The comedown, the "Tuesday blues," typically peaks two to four days after use as serotonin runs low.

No FDA med

Therapy-led treatment

There is no FDA-approved medication for MDMA use disorder, so behavioral therapy is the core of care.

Adulterated

What is in the pill

Per the DEA, ecstasy and molly are frequently cut with other substances, so we assess what you actually took.

Serotonin

The system MDMA floods

MDMA causes a large release of serotonin, which is why the days afterward can feel so empty.

Trusted in-network insurance partnerships

Kayla Borja Frost

Chief Clinical Officer

This page was clinically and medically reviewed for accuracy and alignment with current addiction medicine standards.

Last Reviewed

July 2026

Rachel Fry 1024x1024 2 1 1

Director Of Nursing

What to Expect, in Numbers

Days 2-4

When the crash peaks The MDMA comedown, the "Tuesday blues," typically peaks two to four days after use as serotonin runs low.

No FDA

For MDMA use disorder There is no FDA-approved medication for MDMA addiction; treatment is behavioral-therapy-led, with medical support for co-occurring conditions.

24/7

Nursing & monitoring Vital sign checks per withdrawal protocol and as needed, with withdrawal scoring by a dedicated detox nursing team, separate from our residential staff.

Priority Admissions

One call starts a simple, guided path that moves you into treatment fast.

Is MDMA Addictive? Yes.

First, the names. MDMA, ecstasy, and molly are the same drug in different forms. Ecstasy usually refers to pressed pills, while molly refers to powder or crystal sold as “pure” MDMA, though purity claims rarely hold up. According to the U.S. Drug Enforcement Administration (DEA), pills and powder sold as ecstasy or molly are frequently adulterated with or replaced by other substances, including methamphetamine, synthetic cathinones (“bath salts”), and in some cases fentanyl.[1] So the very first clinical question is not just how much MDMA someone used, but what was actually in it.

 

Can MDMA be addictive? Yes. According to the National Institute on Drug Abuse (NIDA), some people who use MDMA develop dependence-type symptoms, continuing to use despite harm, building tolerance, and experiencing withdrawal-like effects when they stop.[2] MDMA acts on the same dopamine, serotonin, and norepinephrine systems that other addictive drugs target. The pull is less about physical dependence and more about the euphoria, emotional openness, and sense of connection MDMA produces, which is exactly what makes it hard to give up for people who have come to rely on it socially or emotionally.

 

MDMA is one of the substances we treat alongside the wider pattern of club and party drug use; if your use spans several substances at events, our club drug addiction treatment program addresses that broader picture.

How MDMA dependence takes hold, one stage at a time

01

It starts with connection, not chaos

What happens: First experiences feel euphoric, open, and deeply social, often at concerts, festivals, or with a close group. The drug gets linked to joy and belonging.

What you feel: Warmth, closeness, and a sense that everything finally feels easy, the memory that makes the next time feel worth it.

02

Tolerance climbs fast

What happens: According to NIDA, tolerance to MDMA builds quickly, so the magic of early experiences fades. Doses escalate and use grows more frequent to chase a feeling that keeps slipping away.

What you feel: The same amount does less, so it takes more to get back to where you started, which is also where adulterated pills and powder raise the risk most.

03

It becomes the only way to feel

What happens: Over time, music, intimacy, and social ease feel flat without MDMA. Emotional openness starts to require the drug, which is the psychological core of the dependence.

What you feel: A sense that you cannot connect, relax, or enjoy a night out without it, which is exactly what makes it so hard to give up.

04

The crash drives the cycle

What happens: Low, anxious, foggy days after use push some people back toward MDMA or other substances for relief, and often into a wider polysubstance pattern.


How we treat it: An integrated dual-diagnosis assessment for the depression and anxiety underneath, plus a check for what you have actually been taking, all under one clinical team.

You may not be taking what you think you are taking.

According to the DEA, pills and powder sold as ecstasy or molly are frequently cut with or substituted by other substances, including methamphetamine, synthetic cathinones (“bath salts”), and in some cases fentanyl. There is no reliable way to know the contents of a street pill, so every use carries unpredictable risk.

 

This is why the first thing we do is figure out what you have actually been taking. Adulterant exposure shapes both the symptoms you feel and the treatment plan we build. If you are worried about your own use or someone else’s, call us at (319) 270-2890 and we will walk you through what assessment looks like.

Comedown or Withdrawal: What Does Coming Off MDMA Feel Like?

Coming off MDMA is not usually a medical emergency the way alcohol or benzodiazepine withdrawal can be. Two things to separate: a comedown is the short crash in the days right after using, the “Tuesday blues,” when depleted serotonin leaves you low, anxious, and foggy. Withdrawal is the broader pattern that emerges with repeated, heavy use: persistent low mood, fatigue, sleep problems, and cravings when you try to stop. MDMA causes a large release of serotonin, which is why the days afterward can feel so empty. Severity varies with dose, frequency, what the pills actually contained, and co-occurring conditions.

last dose illustrative

The first days after use

Mood drops, anxiety and irritability rise, sleep and appetite are disrupted, and thinking turns foggy as serotonin runs low.

Care:
Monitor mood and safety, restore sleep and hydration, support nutrition.

The low deepens midweek

After weekend use the low deepens midweek, with sadness, low motivation, and emotional flatness. Many people use again, or reach for another substance for relief.

Care:
Daily mood tracking, non-addictive supportive medications when indicated.

Serotonin signaling recovers

Serotonin signaling recovers, energy and mood improve in stretches, sleep repairs, and emotional range returns; cravings can still surface. Therapy gains traction.

Now:
Therapy gains traction as the brain recalibrates.

The long recalibration

With heavy or long-term use, low mood, memory and concentration problems, and intermittent cravings can persist. Relapse prevention targets the social and emotional triggers.

Focus:
Relapse prevention for social and emotional triggers.

Is MDMA Neurotoxic?

Heavy or repeated use can harm the brain’s serotonin system. MDMA triggers a large release of serotonin, which regulates mood, sleep, appetite, and emotion, and frequent use may damage the neurons that produce it, linked to longer-term problems with mood, memory, sleep, and impulse control.[3] The encouraging part: some effects appear to improve with sustained abstinence as the serotonin system recovers, though questions about lasting changes remain under study. The more often and the higher the dose, the greater the risk, and stopping is the most direct way to protect long-term mental health.

Release: the flood

According to NIDA, MDMA causes a large release of serotonin all at once. That surge produces the euphoria, emotional openness, and connection people seek, but it spends the brain’s supply far faster than it can be replaced.

Depletion: the crash

Once the surge is spent, serotonin runs low. This depletion drives the comedown and the “Tuesday blues,” and with repeated, heavy use it can contribute to lasting low mood, anxiety, and problems with memory and concentration.

Recovery: the repair

NIDA notes that some serotonin-system effects appear to improve with sustained abstinence as the system recovers, though questions about lasting changes remain under study. Stopping, and giving the brain a real chance to heal, is the most direct way to protect long-term mental health.

Serotonin depletion and mood

A large serotonin release followed by depletion drives the crash and, with repeated use, can contribute to lasting low mood and anxiety per NIDA.

Memory and concentration

Research links frequent MDMA use to problems with memory and concentration that can outlast the acute comedown.

Recovery with abstinence

Some serotonin-system effects appear to improve over time without use, which is one reason sustained, supported recovery matters.

How Do You Treat MDMA Addiction Without a Medication for It?

Honest answer first: there is currently no FDA-approved medication to treat MDMA use disorder. Unlike opioid or alcohol use disorders, there is no maintenance medication that blocks or replaces MDMA. NIDA is clear that the evidence-based standard for substances like MDMA is behavioral treatment, alongside medical stabilization and a dual-diagnosis assessment, because depression and anxiety so often sit underneath MDMA, ecstasy, and molly use, both as causes and consequences of serotonin depletion.

There is no pill for this. Here is what works instead.

Cognitive behavioral therapy

CBT identifies the situations, beliefs, and feelings tied to use, the “I cannot connect or have fun without it” thinking, then builds coping skills and new routines for social and emotional life without MDMA.

Motivational interviewing

MI meets the genuine ambivalence many people feel, because MDMA gave them real connection and joy, without lecturing, and builds change on your own reasons rather than someone else’s.

Integrated dual-diagnosis care

Structured screening and treatment for co-occurring depression and anxiety, one team and one plan rather than a referral out. We use supportive, non-addictive medications for those conditions when indicated.

Medical stabilization

24/7 nursing and mood monitoring during the crash, plus honest education. MDMA-assisted therapy is an investigational treatment studied in controlled trials with licensed therapists and pharmaceutical-grade MDMA; the FDA declined to approve it in 2024 and requested more research, so it is not an approved treatment and is entirely different from recreational use.
Sources: NIDA, MDMA Research Report and Principles of Drug Addiction Treatment; U.S. Food and Drug Administration, 2024 decision declining approval of MDMA-assisted therapy.

You Can Feel Like Yourself Again

You do not need to know exactly what you took or have the right words for it. Tell our admissions team what the nights and the mornings after look like, and we will explain what assessment, detox, and treatment would mean for your situation, in one confidential call.

Where Treatment Fits in Your Full Recovery

Getting through the crash is not the same as treating the addiction. The acute comedown passes in days; the patterns underneath, the belief that connection and joy require MDMA, the depression or anxiety driving use, the wider polysubstance scene, take structured work over weeks and months. NIDA finds that longer engagement produces better outcomes. We run the entire continuum under one roof in Cedar Rapids, with one clinical team.

All levels of care on one campus in Cedar Rapids, under one clinical team.

Most clinical → Independent

Residential inpatient

Structured programming, CBT, and dual diagnosis care in our restored Higley Mansion facility, with depth set by your use history and co-occurring conditions.

Partial hospitalization (PHP)

Several hours of clinical programming daily with off-site living, a strong middle path as mood stabilizes.

Intensive outpatient (IOP)

Continued therapy built around work, school, and family, with the same clinical team.

Standard outpatient and continuing care

Weekly therapy, relapse prevention, and ongoing mental-health support for as long as it helps.

Alumni and aftercare

Long-term connection to the alumni community, recovery events, and a team that stays reachable.

If MDMA became the way you connect, relax, or feel anything at all, that is not a character flaw. It is what the drug does to serotonin. Our job is to treat the use and the depression or anxiety sitting underneath it, at the same time.

Kayla Borja Frost

Kayla Borja Frost, LMHC, IADC

Chief Clinical Officer, Radix Recovery

MDMA Addiction Treatment for Residents Across Iowa

Our facility sits in Cedar Rapids, and people come to us from every corner of the state. For many people whose MDMA use is tied to a specific club, festival, or social scene, putting distance between themselves and those settings is a clinical advantage. Our admissions team coordinates travel, family communication where you want it, and insurance for every Iowa community we serve.
Cedar Rapids

Our Location

Iowa City

~30 min

Davenport

~1.5 hrs

Quad Cities

~1.5 hrs

Dubuque

~1.5 hrs

Marion

~10 min

Des Moines

~2 hrs

Ankeny

~2 hrs

West Des Moines

~2 hrs

Ames

~1.5 hrs

Waterloo

~1 hr

Cedar Falls

~1 hr

Sioux City

~3.5 hrs

Council Bluffs

~3 hrs

Cedar Rapids, Iowa

A space built for getting well

Move through the facility one room at a time, the living spaces, the gathering rooms, and the grounds where residents reconnect with themselves.

Now viewing Your first step in
Reception
Bedrooms
Lounge
Dining
Fitness
Therapy
01 · Arrival Reception Where arrival feels less like checking in and more like being expected.
02 · Living Bedrooms Comfortable, restful rooms that feel like a real place to heal, not a hospital.
03 · Comfort Lounge and library Quiet corners to read, reflect, or simply sit with your thoughts.
04 · Dining Dining and kitchen A warm, shared table where residents gather over real, home-style meals.
05 · Wellness Fitness center Equipment and open room to rebuild physical strength alongside the mind.
06 · Healing Therapy rooms Private, comfortable rooms built for honest individual and group work.
1 / 6

Credibility you can verify

Every figure here is documented, licensed, or independently reviewed, so you can check it yourself before you ever call.

Listed by the State of
Iowa

Radix is a listed treatment provider on Your Life Iowa, the official addiction-help resource run by the Iowa Department of Health & Human Services.

0 +

Years of combined
clinical experience

Across the Radix clinical leadership team, from the founding partners to the chief clinical officer.

154 1548379 google 5 stars png star transparent png removebg preview 1

Excellent Rating on
Google

Across client reviews of admissions, counseling, detox, and residential care.

Joint Commission
Accredited

The national standard for safety, treatment quality, and staff training in healthcare.

Why Families Trust Radix Recovery

Real outcomes from real people. Hear what our clients and their loved ones have to say about their time in our program.

Your Questions About MDMA Treatment answered

MDMA can be addictive, though it works differently from drugs like opioids or alcohol. According to the National Institute on Drug Abuse (NIDA), some people who use MDMA report dependence symptoms such as continued use despite harm, tolerance, and withdrawal-like effects. MDMA acts on the same dopamine, serotonin, and norepinephrine systems targeted by other addictive drugs, and animals will self-administer it. Because it is often used alongside other substances, untangling MDMA dependence from a broader pattern is part of a proper clinical assessment.
MDMA has a lower physical dependence profile than opioids, alcohol, or benzodiazepines, and it does not produce the same dangerous physical withdrawal. The pull is mostly psychological: a craving for the euphoria, emotional openness, and connection MDMA produces. NIDA notes that MDMA affects the brain’s reward circuitry in ways similar to other addictive substances, and that tolerance builds quickly, pushing some users toward heavier, more frequent doses. The danger is less about physical addiction and more about escalating use and serotonin depletion.
Yes, some people do develop a problematic, compulsive pattern of MDMA use. It often shows up as needing the drug to feel social, to enjoy music or events, or to access emotion. Tolerance climbs fast, so the magic of early experiences fades and doses escalate to chase it. According to NIDA, MDMA can produce dependence-type symptoms in a subset of users. If MDMA has become central to how you connect, relax, or feel like yourself, that is worth taking seriously, with or without a formal diagnosis.
No. A single use of MDMA does not create addiction. Addiction develops over repeated use as tolerance builds and the brain begins to associate the drug with reward, social connection, and relief. That said, even occasional MDMA use carries real risks, including acute effects like overheating and dangerous interactions, and the very common problem that pressed pills and powder sold as MDMA are frequently adulterated with other substances. Risk is not the same as addiction, but both matter.
A comedown is the short crash in the days right after using MDMA, often called the “Tuesday blues” or midweek crash, when depleted serotonin leaves you low, anxious, irritable, and foggy for a few days. Withdrawal refers to the broader pattern that can emerge with repeated, heavy use: persistent low mood, sleep problems, fatigue, and cravings when you try to stop. The comedown resolves on its own; ongoing withdrawal-type symptoms and cravings are signs that use has become a pattern worth treating.
Research suggests heavy or repeated MDMA use can harm the brain’s serotonin system. NIDA reports that MDMA causes a large release of serotonin, and that frequent use may damage serotonin-producing neurons, contributing to longer-term problems with mood, memory, sleep, and impulse control. Some of these effects appear to improve with sustained abstinence, while questions about lasting changes remain under study. The practical takeaway is that the more often and the higher the dose, the greater the risk to mood and memory over time.
They are not the same thing. MDMA-assisted therapy is an investigational treatment studied in tightly controlled clinical trials, with pharmaceutical-grade MDMA, careful screening, and licensed therapists present throughout. In 2024, the U.S. Food and Drug Administration declined to approve MDMA-assisted therapy and requested additional research, so it is not an FDA-approved treatment. Recreational MDMA use involves unregulated, frequently adulterated substances taken without medical oversight. The research context does not make recreational use safe, and it does not address compulsive use.

Often it is not. The U.S. Drug Enforcement Administration (DEA) reports that pills and powder sold as ecstasy or molly are frequently adulterated with or substituted by other substances, including methamphetamine, synthetic cathinones (“bath salts”), and in some cases fentanyl. Because there is no way to know the contents of a street pill, every use carries unpredictable risk. At Radix Recovery, we assess for exposure to these adulterants, because what someone has actually been taking shapes both their symptoms and their treatment plan.

There is currently no FDA-approved medication to treat MDMA use disorder, which makes treatment different from opioid or alcohol care. The evidence-based foundation is behavioral therapy, primarily cognitive behavioral therapy and motivational interviewing, supported by medical stabilization and a thorough dual-diagnosis assessment. Because depression and anxiety are so common alongside MDMA use, our medical providers may treat those co-occurring conditions with appropriate, non-addictive medications when indicated. The core work, though, is therapeutic, not pharmacological.

Medical stabilization and a full assessment typically take a few days. From there, we recommend residential treatment in 30, 60, or 90-day pathways depending on use history and co-occurring conditions, followed by step-down through PHP, IOP, and outpatient care. National Institute on Drug Abuse research consistently shows that longer engagement in treatment produces better outcomes. Because MDMA use is so often part of a wider polysubstance and mental health picture, the full continuum gives us room to treat everything driving the use.
In most cases, yes. We are in-network with Wellmark Blue Cross Blue Shield, TriWest Healthcare Alliance, Midlands Choice, Cigna Healthcare, Health Choice, and Medical Associates, and we work with many other plans. Substance use disorder treatment is an essential health benefit under federal parity law. Call (319) 270-2890 or use our confidential insurance verification form, and our admissions team will confirm your exact coverage at no cost and with no obligation.
Yes. Our facility is in Cedar Rapids, and people come to us from across Iowa, including Des Moines, Iowa City, Davenport, Waterloo, Dubuque, and the Quad Cities. For many people whose MDMA use is tied to a specific club, festival, or social scene, putting distance between themselves and those settings is a clinical advantage. Our admissions team coordinates travel, family communication, and insurance for every Iowa community we serve.

Take the First Step Toward Lasting Recovery.

If MDMA has become the only way you know how to connect, relax, or feel something, that is not a character flaw, and you do not have to untangle it alone. One confidential call connects you with a team that treats the use and the depression or anxiety underneath it, and we can usually have you admitted within 24 hours.

Primary clinical sources

01

U.S. Drug Enforcement Administration (DEA)

02
National Institute on Drug Abuse (NIDA)